Medivie Therapeutic Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 2
Employees
  • Stock Symbol
  • MDVI
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $5.33
  • (As of Thursday Closing)

Medivie Therapeutic General Information

Description

Medivie Therapeutic Ltd is engaged in the development of dental support devices (DSD) for a variety of medical uses. It currently markets a DSD designed to help deal with the pain of childbirth and to reduce the time spent in labor. This company is also engaged in developing a DSD solution for migraine pain and to improve concentration and cognitive activity.

Contact Information

Website
www.medivie.com
Formerly Known As
OPRO Mother & Baby
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Other Industries
Other Devices and Supplies
Stock Exchange
TAE
Primary Office
  • 1 The Willows
  • Mark Road, Herts
  • Hemel Hempstead HP2 7BN
  • England, United Kingdom
+44 01442 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medivie Therapeutic Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.33 $4.95 $1.24 - $9.11 $15.3M 2.88M 25.8K -$0.77

Medivie Therapeutic Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 4,910 4,910 3,907 19,271
Revenue 143 143 136 0
EBITDA (1,500) (1,500) (1,332) (650)
Net Income (1,916) (1,916) (3,246) (476)
Total Assets 3,792 3,792 3,896 4,381
Total Debt 891 891 880 495
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medivie Therapeutic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medivie Therapeutic‘s full profile, request access.

Request a free trial

Medivie Therapeutic Executive Team (5)

Name Title Board Seat Contact Info
Shanon Palombo Chief Financial Officer
Roberto Lifschitz Chief Scientist
Anthony Lovat Founder
You’re viewing 3 of 5 executive team members. Get the full list »

Medivie Therapeutic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medivie Therapeutic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medivie Therapeutic‘s full profile, request access.

Request a free trial

Medivie Therapeutic Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 000000 01-Nov-2017 000000000000000000 Pharmaceuticals
Glycominds 01-Apr-2014 Merger/Acquisition Diagnostic Equipment
To view Medivie Therapeutic’s complete acquisitions history, request access »

Medivie Therapeutic Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 000000 01-Nov-2017 000000000000000000 Completed
  • 0000000 0000000000
To view Medivie Therapeutic’s complete exits history, request access »